Target intelligence / Profile preview

Enamel matrix protein (EMP)

Target
EMP
Molecular classification
Other
01

Overview

Enamel matrix proteins (EMPs) represent a diverse group of secreted, primarily tooth-specific proteins including **amelogenin**, **enamelin**, **ameloblastin** (also known as amelin or sheathlin), **tuftelin**, and **amelotin**[2][4][8]. These proteins are mainly produced by ameloblasts during enamel formation and collectively make up the organic matrix of developing enamel, where they regulate the nucleation, growth, and organization of hydroxyapatite crystals, resulting in the highly mineralized structure of tooth enamel[2][6][8]. Amelogenin constitutes the majority (about 90%+) of the EMPs and is key for the development and architecture of enamel[3][5][6]. Additional roles for EMPs include initiation of cementum (root covering) deposition, periodontal attachment formation (through derivatives such as EMD), and possibly non-canonical biological effects outside dental tissues (e.g., growth factor-like activity, signaling, calcium metabolism)[3][4][8]. Mutations in genes coding for EMPs are linked to dental disorders such as amelogenesis imperfecta[1]. EMP derivatives, particularly EMD (Emdogain), are used in regenerative periodontal therapy[7]. EMPs are not a single druggable molecular target, receptor, or enzyme but rather a protein family or mixture, and thus should not be listed as a conventional therapeutic target; instead, specific members (e.g., amelogenin, enamelin) may have more structured target entries. The term "enamel matrix proteins" is generic, referring collectively to several related and functionally interconnected proteins, and does not describe a single molecular target suitable for most drug discovery or receptor-oriented frameworks. For structured applications, each major component (e.g., "Amelogenin", "Enamelin") should be treated as distinct entries. EMPs themselves act as structural and functional mediators but are not classic receptors, enzymes, or transporters. Their use in therapy is through protein extracts (EMD), not small-molecule modulation of a defined target[3][7].

Other names
Enamel matrix proteins (EMPs)Enamel proteinsEMP
02

Mechanism of action

Biomimetic stimulation of tissue regeneration; modulation of cellular differentiation and proliferation; enhancement of periodontal ligament and bone regeneration

03

Biological functions

Enamel biomineralizationTooth developmentCementogenesisModulation of hydroxyapatite crystal growthPossible growth factor-like activityPossible cell signaling
04

Disease associations

Amelogenesis imperfectaPeriodontal diseaseOther dental developmental defects
05

Safety considerations

Clinical use (such as Emdogain) can rarely cause hypersensitivitythere may be concerns regarding xenogenic (porcine) origin in some patients
06

Interacting drugs

Emdogain (enamel matrix protein derivative, used therapeutically in periodontology)
07

Biomarkers

Mutations in EMP genes (especially amelogenin, enamelin) as biomarkers for amelogenesis imperfecta

Beyond the preview

Go deeper on Enamel matrix protein (EMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enamel matrix protein (EMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call